Trial intelligence / Profile preview

Oliceridine and Propofol for Sedation in Obese Patients Undergoing Gastrointestinal Endoscopy

NCT07759778Phase 4Not yet recruiting

Start
Aug 2026
Primary completion
Feb 2027
01

Overview

A Phase 4 trial of oliceridine. Planned start Aug 2026; status: not yet recruiting.

02

Drugs

oliceridine

Beyond the preview

Go deeper on NCT07759778.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07759778.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call